Angiogenic Growth Factors in Cardiac Allograft Rejection
Authors:
- Jussi M. TikkanenJTJussi M. Tikkanen
- Rainer KrebsRKRainer Krebs
- Mikko A. I. KeränenMKMikko A. I. Keränen
- Roope K. SihvolaRSRoope K. Sihvola
- Henrik SandelinHSHenrik Sandelin
- Raimo TuuminenRTRaimo Tuuminen
- Olivier RaiskyOROlivier Raisky
- Petri K. KoskinenPKPetri K. Koskinen
- Karl B. LemströmKLKarl B. Lemström
- 15 July 2006
- journal article
- review article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 82 (Supplement) , S22-S24
Abstract
Normal adult vasculature is in a quiescent state. In transplanted hearts, peri- and postoperative ischemic and alloimmune stimuli may be interpreted as inadequate tissue perfusion leading to activation of angiogenic signaling. Although this may have protective functions, improper activation of cardiac allograft endothelial cells and smooth muscle cells may actually result in impaired survival of cardiac allografts. In this paper, we review the current knowledge on angiogenic growth factors, vascular endothelial growth factor, angiopoietins, and platelet-derived growth factor in cardiac allografts. We also discuss the potential for therapies aimed at angiogenic growth factors in preventing and treating cardiac allograft rejection and transplant coronary artery disease.Keywords
This publication has 28 references indexed in Scilit:
- Pathophysiological consequences of VEGF-induced vascular permeabilityNature, 2005
- The biology of vascular endothelial growth factorsCardiovascular Research, 2005
- The PDGF family: four gene products form five dimeric isoformsCytokine & Growth Factor Reviews, 2004
- Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunityNature Medicine, 2004
- Cardiac allograft vasculopathy: central role of endothelial injury leading to transplant ???atheroma???Transplantation, 2003
- Tie receptors: new modulators of angiogenic and lymphangiogenic responsesNature Reviews Molecular Cell Biology, 2001
- Chronic RejectionImmunity, 2001
- Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathwayOncogene, 2000
- VASCULAR ENDOTHELIAL GROWTH FACTOR EXPRESSION IN TRANSPLANTED HUMAN HEARTS1,2Transplantation, 1995
- Local Delivery of Vascular Endothelial Growth Factor Accelerates Reendothelialization and Attenuates Intimal Hyperplasia in Balloon-Injured Rat Carotid ArteryCirculation, 1995